by Jason Farmer | Jul 30, 2026 | Compliance & Risk
CMS built five metrics into GUIDE that directly affect payment – including two developed specifically for this model. Understanding the measurement methodology is not an academic exercise; it determines whether you receive a bonus or a penalty. Key TakeawaysFive...
by Jason Farmer | Jul 24, 2026 | Compliance & Risk
DEA enforcement against pain practices intensified through 2025 and into 2026. The practices that survive scrutiny share one thing: a prescribing program that was documented, consistent, and already running before the auditor arrived. Key TakeawaysEvery state now...
by Jason Farmer | May 31, 2026 | Compliance & Risk
Compounding, telehealth, and advertising. The rules on all three moved substantially between 2024 and 2026, and the enforcement is no longer theoretical. Key TakeawaysFDA’s compounding page, updated April 1, 2026, states that tirzepatide and semaglutide do not...
by Jason Farmer | Apr 16, 2026 | Compliance & Risk
Obstetricians face some of the highest medical malpractice premiums in medicine, with major geographic variation and a seventh consecutive year of rising rates recorded in 2025. Premium management is not a passive activity – several factors within a...
by Jason Farmer | Mar 6, 2026 | Compliance & Risk
Anesthesia billing is built on a unit-based formula that is unlike any other specialty. The 2026 conversion factor is $20.4976. But the modifiers – QK, QY, QZ, and AD – determine whether you collect 50 percent, 100 percent, or three base units. Get them...
by Jason Farmer | Feb 13, 2026 | Compliance & Risk
The documentation failures that cost outpatient physical therapy practices money are not exotic. CMS publishes the list. Most practices have never read it. Key TakeawaysOIG reviewed 300 outpatient physical therapy claims and found 61 percent did not comply with...